Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients
Clinical trial NCT03459287 · COMPLETED
Trial details
- NCT number
- NCT03459287
- Sponsor
- Cerus Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2023-12-04
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.